There were no differences in QoL and cognition at initial assessment, but Improvers showed a trend toward increased processing speed and decreased sleep disturbance after 3 months.
← all excerpts
Characterizing Neuro-PASC outcome with the mobile Neuro-COVID recovery care companion application.
1
—
—